Malonganenone A is an antimalarial marine alkaloid that disrupts the interaction between PfHsp70-x and Hsp40; it selectively inhibits Plasmodium falciparum Hsp70 ATPase activity (stimulated by Hsp40) over human Hsp70, and impairs the anti-aggregation activity of PfHsp70-x.